Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : General market lab and commentary -- Ignore unavailable to you. Want to Upgrade?

To: Robohogs who wrote (272)	3/21/2016 10:59:32 AM
From: scaram(o)uche	Respond to of 668

Innovative medicines, under patent, will never be needed again. Should sell at a slight premium to dirt. (Hospital costs, apart from medicines, expected to quadruple next year, as biotechs just stop selling drugs for HCV, CML, etc. Bakeries converted to pill factories as source of pain medications.)

To: Robohogs who wrote (272)	3/21/2016 11:16:15 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 668

Add that there is a global aging trend. Old people don't need medicine, let's just thin out the population. Next viral or bacterial "plague" will be a good thing, just let it run course. Innovative research worthless, quite obviously. Get used to it.